Law ❯ Securities Law ❯ Class Action ❯ Investor Rights

Litigation

aTyr Investor Lawsuit Drive Heats Up as Dec. 8 Lead-Plaintiff Deadline Nears

Filings accuse aTyr of overstating efzofitimod’s ability to enable complete steroid tapering.

Savara Securities Case Nears Lead‑Plaintiff Deadline as Firms Court Investors

Cytokinetics Investors Urged to Act as Lead‑Plaintiff Deadline Nears in REMS‑Related Securities Suit

Nutex Investors Face Oct. 21 Deadline in Securities Class Action Over HaloMD and Accounting Claims

Savara Investors Face Nov. 7 Lead‑Plaintiff Deadline in Securities Suit Over FDA Refusal‑to‑File

Charter Faces Securities Class Action Over ACP Disclosures in SDNY

Altimmune Investors Urged to Seek Lead Role in Securities Suit as Oct. 6 Deadline Nears

Lineage Investors Face Sept. 30 Deadline in Securities Class Action Over IPO Disclosures

Class Action Targets Fly‑E Over Alleged Battery Safety Misstatements

Fiserv Investors Face Sept. 22 Deadline to Seek Lead Role in Securities Class Action

Flywire Investors Urged to Act as Lead‑Plaintiff Deadline Nears in Securities Suit

Alto Neuroscience Investors Urged to Seek Lead Plaintiff Status by Sept. 19

Biohaven Investors Face Sept. 12 Deadline in Securities Class Action